Post Biopsy Cavity Treatment Implants and Methods
AssigneeRubicor Medical, Inc.
InventorsAry S. Chernomorsky, James W. Vetter, Simon Chernomorsky
Life of this patent
Estimating the term…
Abstract
A post-biopsy cavity treatment implant includes a radiopaque element, a core portion and a shell portion. The core portion is coupled to the radiopaque element, and includes a first porous matrix defining a first controlled pore architecture. The shell portion is coupled to the core portion and includes a second porous matrix defining a second controlled pore architecture that is different from the first controlled pore architecture.
Claims66
A post-biopsy cavity treatment implant, comprising:
- a radiopaque element;
- a core portion coupled to the radiopaque element, the core portion including a first porous matrix defining a first controlled pore architecture, and
- a shell portion coupled to the core portion, the shell portion including a second porous matrix defining a second controlled pore architecture that is different from the first controlled pore architecture.
A post-biopsy cavity treatment implant, comprising:
- at least one radiopaque element;
- a core portion coupled to the at least one radiopaque element, the core portion including a first porous matrix defining a first controlled pore architecture, the core portion including at least one of a polylactide (PLA), a polyglycolide (PGA), a poly(lactide-co-glycolide) (PLGA) and a polyglyconate, and
- a collagenous shell portion coupled to the core portion, the collagenous shell portion including a second porous matrix defining a second controlled pore architecture that is different from the first controlled pore architecture.
A method of treating a cavity created by a percutaneous excisional procedure carried out through an incision, comprising the steps of:
- providing a post-procedure cavity implant, the post-procedure cavity implant including a radiopaque element;
- a core portion coupled to the radiopaque element, the core portion including a first porous matrix defining a first controlled pore architecture, and a shell portion coupled to the core portion, the shell portion including a second porous matrix defining a second controlled pore architecture that is different from the first controlled pore architecture;
- implanting the post-procedure cavity implant into the cavity, and
- closing the incision.
Dependencies are inferred from the claim text.